• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症研究的不良事件捕获与管理系统。

An adverse event capture and management system for cancer studies.

作者信息

Lencioni Alex, Hutchins Laura, Annis Sandy, Chen Wanchi, Ermisoglu Emre, Feng Zhidan, Mack Karen, Simpson Kacie, Lane Cheryl, Topaloglu Umit

出版信息

BMC Bioinformatics. 2015;16 Suppl 13(Suppl 13):S6. doi: 10.1186/1471-2105-16-S13-S6. Epub 2015 Sep 25.

DOI:10.1186/1471-2105-16-S13-S6
PMID:26424052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4597098/
Abstract

BACKGROUND

Comprehensive capture of Adverse Events (AEs) is crucial for monitoring for side effects of a therapy while assessing efficacy. For cancer studies, the National Cancer Institute has developed the Common Terminology Criteria for Adverse Events (CTCAE) as a required standard for recording attributes and grading AEs. The AE assessments should be part of the Electronic Health Record (EHR) system; yet, due to patient-centric EHR design and implementation, many EHR's don't provide straightforward functions to assess ongoing AEs to indicate a resolution or a grade change for clinical trials.

METHODS

At UAMS, we have implemented a standards-based Adverse Event Reporting System (AERS) that is integrated with the Epic EHR and other research systems to track new and existing AEs, including automated lab result grading in a regulatory compliant manner. Within a patient's chart, providers can launch AERS, which opens the patient's ongoing AEs as default and allows providers to assess (resolution/ongoing) existing AEs. In another tab, it allows providers to create a new AE. Also, we have separated symptoms from diagnoses in the CTCAE to minimize inaccurate designation of the clinical observations. Upon completion of assessments, a physician would submit the AEs to the EHR via a Health Level 7 (HL7) message and then to other systems utilizing a Representational State Transfer Web Service.

CONCLUSIONS

AERS currently supports CTCAE version 3 and 4 with more than 65 cancer studies and 350 patients on those studies. This type of standard integrated into the EHR aids in research and data sharing in a compliant, efficient, and safe manner.

摘要

背景

全面收集不良事件(AE)对于在评估疗效时监测治疗的副作用至关重要。对于癌症研究,美国国立癌症研究所已制定了不良事件通用术语标准(CTCAE),作为记录不良事件属性和分级的必需标准。不良事件评估应成为电子健康记录(EHR)系统的一部分;然而,由于以患者为中心的电子健康记录设计和实施,许多电子健康记录并未提供直接功能来评估正在发生的不良事件,以表明临床试验中的缓解情况或分级变化。

方法

在阿肯色大学医学科学分校(UAMS),我们实施了一个基于标准的不良事件报告系统(AERS),该系统与Epic电子健康记录和其他研究系统集成,以跟踪新的和现有的不良事件,包括以符合法规的方式自动进行实验室结果分级。在患者病历中,医疗服务提供者可以启动AERS,它默认打开患者正在发生的不良事件,并允许医疗服务提供者评估(缓解/正在发生)现有的不良事件。在另一个标签中,它允许医疗服务提供者创建新的不良事件。此外,我们在CTCAE中将症状与诊断分开,以尽量减少临床观察的错误指定。评估完成后,医生将通过健康级别7(HL7)消息将不良事件提交到电子健康记录,然后通过代表性状态转移网络服务提交到其他系统。

结论

AERS目前支持CTCAE第3版和第4版,有超过65项癌症研究以及参与这些研究的350名患者。这种集成到电子健康记录中的标准有助于以合规、高效和安全的方式进行研究和数据共享。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/3c0b9be82da4/1471-2105-16-S13-S6-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/635eb75124a0/1471-2105-16-S13-S6-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/501e106b0324/1471-2105-16-S13-S6-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/8366bb698939/1471-2105-16-S13-S6-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/898fd4bb4256/1471-2105-16-S13-S6-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/2400058f75ad/1471-2105-16-S13-S6-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/597dc3661c2a/1471-2105-16-S13-S6-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/dd70f05dd3ff/1471-2105-16-S13-S6-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/b657d35a86b1/1471-2105-16-S13-S6-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/3c0b9be82da4/1471-2105-16-S13-S6-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/635eb75124a0/1471-2105-16-S13-S6-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/501e106b0324/1471-2105-16-S13-S6-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/8366bb698939/1471-2105-16-S13-S6-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/898fd4bb4256/1471-2105-16-S13-S6-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/2400058f75ad/1471-2105-16-S13-S6-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/597dc3661c2a/1471-2105-16-S13-S6-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/dd70f05dd3ff/1471-2105-16-S13-S6-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/b657d35a86b1/1471-2105-16-S13-S6-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/4597098/3c0b9be82da4/1471-2105-16-S13-S6-9.jpg

相似文献

1
An adverse event capture and management system for cancer studies.用于癌症研究的不良事件捕获与管理系统。
BMC Bioinformatics. 2015;16 Suppl 13(Suppl 13):S6. doi: 10.1186/1471-2105-16-S13-S6. Epub 2015 Sep 25.
2
Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).使用美国国家癌症研究所的患者报告结局版常见不良事件术语标准(PRO-CTCAE),对癌症临床研究中的症状性不良事件进行患者自由文本报告。
J Am Med Inform Assoc. 2019 Apr 1;26(4):276-285. doi: 10.1093/jamia/ocy169.
3
Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).癌症临床试验中的患者报告结局:使用美国国立癌症研究所不良事件通用术语标准的患者报告结局版本(PRO-CTCAE)测量症状性不良事件。
Am Soc Clin Oncol Educ Book. 2016;35:67-73. doi: 10.1200/EDBK_159514.
4
Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.将儿童和青少年自我报告的症状数据与临床医生报告的不良事件分级进行映射,以改善儿科肿瘤学的护理和研究。
Cancer. 2020 Jan 1;126(1):140-147. doi: 10.1002/cncr.32525. Epub 2019 Sep 25.
5
Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library.使用完整的患者报告结局版常见不良事件术语标准(PRO-CTCAE)项目库的可行性评估。
Oncologist. 2019 Apr;24(4):e146-e148. doi: 10.1634/theoncologist.2018-0332. Epub 2019 Feb 6.
6
Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial.从患者角度评估 III 期转移性去势抵抗性前列腺癌临床试验中的不良事件。
JAMA Oncol. 2020 Feb 1;6(2):e193332. doi: 10.1001/jamaoncol.2019.3332. Epub 2020 Feb 13.
7
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).国家癌症研究所患者报告结局版通用不良事件术语标准(PRO-CTCAE)的制定。
J Natl Cancer Inst. 2014 Sep 29;106(9). doi: 10.1093/jnci/dju244. Print 2014 Sep.
8
Use of the National Cancer Institute Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to assess treatment tolerability in pulmonary arterial hypertension: qualitative patient research findings in current and former users of oral selexipag.采用国家癌症研究所患者报告结局版通用不良事件术语标准评估肺动脉高压治疗耐受性:口服塞乐西帕的现用和曾用患者定性研究结果。
J Patient Rep Outcomes. 2023 Dec 18;7(1):134. doi: 10.1186/s41687-023-00673-w.
9
Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency.改善临床试验中不良事件数据的收集:国际原子能机构的作用。
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1218-21. doi: 10.1016/j.ijrobp.2007.04.054. Epub 2007 Aug 6.
10
Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events.美国国家癌症研究所患者报告结局通用术语标准不良事件的韩语版的可靠性和有效性。
J Pain Symptom Manage. 2020 May;59(5):1082-1088.e6. doi: 10.1016/j.jpainsymman.2020.01.015. Epub 2020 Feb 8.

引用本文的文献

1
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.利用自动化电子健康记录提取技术确定的儿科白血病课程中的实验室不良事件发生率:来自儿童肿瘤学组的回顾性队列研究。
Lancet Haematol. 2022 Sep;9(9):e678-e688. doi: 10.1016/S2352-3026(22)00168-5. Epub 2022 Jul 20.
2
Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib Iodine Implantation.经动脉化疗栓塞联合索拉非尼碘植入治疗伴门静脉瘤栓的肝细胞癌
Front Oncol. 2021 Dec 23;11:806907. doi: 10.3389/fonc.2021.806907. eCollection 2021.
3

本文引用的文献

1
Improving patient safety via automated laboratory-based adverse event grading.通过自动化基于实验室的不良事件分级来提高患者安全性。
J Am Med Inform Assoc. 2012 Jan-Feb;19(1):111-5. doi: 10.1136/amiajnl-2011-000513. Epub 2011 Nov 14.
2
Quality of methods for assessing and reporting serious adverse events in clinical trials of cancer drugs.癌症药物临床试验中严重不良事件评估和报告方法的质量。
Clin Pharmacol Ther. 2010 Aug;88(2):231-6. doi: 10.1038/clpt.2010.79. Epub 2010 Jun 23.
3
Does error and adverse event reporting by physicians and nurses differ?
Serious Adverse Events Reporting in Phase III Randomized Clinical Trials of Colorectal Cancer Treatments: A Systematic Analysis.
结直肠癌治疗 III 期随机临床试验中的严重不良事件报告:一项系统分析。
Front Pharmacol. 2021 Nov 18;12:754858. doi: 10.3389/fphar.2021.754858. eCollection 2021.
4
Evaluating the Coverage of the HL7 FHIR Standard to Support eSource Data Exchange Implementations for use in Multi-Site Clinical Research Studies.评估 HL7 FHIR 标准的覆盖范围,以支持用于多站点临床研究的电子源数据交换实施。
AMIA Annu Symp Proc. 2021 Jan 25;2020:472-481. eCollection 2020.
5
Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery.血液学临床试验不良事件报告的演变,以改善护理服务。
Curr Hematol Malig Rep. 2021 Apr;16(2):126-131. doi: 10.1007/s11899-021-00627-3. Epub 2021 Mar 30.
6
Improving symptom control and reducing toxicities for pediatric patients with hematological malignancies.改善血液系统恶性肿瘤患儿的症状控制,减少毒性。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):280-286. doi: 10.1182/hematology.2020000114.
7
Accelerating the Adoption of eSource in Clinical Research: A Transcelerate Point of View.加速电子源在临床研究中的采用:Transcelerate 的观点。
Ther Innov Regul Sci. 2020 Sep;54(5):1141-1151. doi: 10.1007/s43441-020-00138-y. Epub 2020 Mar 3.
8
Use of EHRs data for clinical research: Historical progress and current applications.电子健康记录(EHRs)数据在临床研究中的应用:历史进展与当前应用
Learn Health Syst. 2019 Jan 16;3(1):e10076. doi: 10.1002/lrh2.10076. eCollection 2019 Jan.
9
TOXICAN: a guide for grading dermatological adverse events of cancer treatments.TOXICAN:癌症治疗皮肤不良反应分级指南。
Support Care Cancer. 2018 Aug;26(8):2871-2877. doi: 10.1007/s00520-018-4153-x. Epub 2018 Mar 12.
10
Using electronic medical record data to report laboratory adverse events.利用电子病历数据报告实验室不良事件。
Br J Haematol. 2017 Apr;177(2):283-286. doi: 10.1111/bjh.14538. Epub 2017 Feb 1.
医生和护士的错误及不良事件报告有差异吗?
Jt Comm J Qual Patient Saf. 2008 Sep;34(9):537-45. doi: 10.1016/s1553-7250(08)34068-9.
4
Reducing diagnostic errors through effective communication: harnessing the power of information technology.通过有效沟通减少诊断错误:利用信息技术的力量
J Gen Intern Med. 2008 Apr;23(4):489-94. doi: 10.1007/s11606-007-0393-z.
5
Diagnostic error in internal medicine.内科诊断错误。
Arch Intern Med. 2005 Jul 11;165(13):1493-9. doi: 10.1001/archinte.165.13.1493.
6
"I wish I had seen this test result earlier!": Dissatisfaction with test result management systems in primary care.“我真希望能早点看到这个检测结果!”:对基层医疗中检测结果管理系统的不满
Arch Intern Med. 2004 Nov 8;164(20):2223-8. doi: 10.1001/archinte.164.20.2223.
7
Improving safety with information technology.利用信息技术提高安全性。
N Engl J Med. 2003 Jun 19;348(25):2526-34. doi: 10.1056/NEJMsa020847.
8
Potential identifiability and preventability of adverse events using information systems.利用信息系统评估不良事件的潜在可识别性和可预防性
J Am Med Inform Assoc. 1994 Sep-Oct;1(5):404-11. doi: 10.1136/jamia.1994.95153428.